Literature DB >> 23413089

Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action.

Yves Pirson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23413089     DOI： 10.1093/ndt/gft009

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  12 in total

Review 1.  Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.

Authors:  S Brakemeier; F Bachmann; K Budde
Journal:  Pediatr Nephrol       Date:  2016-09-01       Impact factor: 3.714

Review 2.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

3.  The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.

Authors:  J Chris Kingswood; Sergiusz Jozwiak; Elena D Belousova; Michael D Frost; Rachel A Kuperman; E Martina Bebin; Bruce R Korf; J Robert Flamini; Michael H Kohrman; Steven P Sparagana; Joyce Y Wu; Thomas Brechenmacher; Karen Stein; Noah Berkowitz; John J Bissler; David N Franz
Journal:  Nephrol Dial Transplant       Date:  2014-04-11       Impact factor: 5.992

4.  Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition.

Authors:  Thierry Krummel; Julien Garnon; Hervé Lang; Afshin Gangi; Thierry Hannedouche
Journal:  BMC Urol       Date:  2014-09-25       Impact factor: 2.264

Review 5.  Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex.

Authors:  María José Buj Pradilla; Teresa Martí Ballesté; Roser Torra; Felipe Villacampa Aubá
Journal:  Clin Kidney J       Date:  2017-09-11

6.  Severe bleeding complications and multiple kidney transplants in a patient with tuberous sclerosis complex caused by a novel TSC2 missense variant.

Authors:  Stela Živčić-Ćosić; Karin Mayer; Gordana Đorđević; Mark Nellist; Marianne Hoogeveen-Westerveld; Damir Miletić; Sanjin Rački; Hanns-Georg Klein; Zlatko Trobonjača
Journal:  Croat Med J       Date:  2017-12-31       Impact factor: 1.351

7.  Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.

Authors:  John J Bissler; Klemens Budde; Matthias Sauter; David N Franz; Bernard A Zonnenberg; Michael D Frost; Elena Belousova; Noah Berkowitz; Antonia Ridolfi; J Christopher Kingswood
Journal:  Nephrol Dial Transplant       Date:  2019-06-01       Impact factor: 5.992

8.  The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.

Authors:  John J Bissler; David N Franz; Michael D Frost; Elena Belousova; E Martina Bebin; Steven Sparagana; Noah Berkowitz; Antonia Ridolfi; J Christopher Kingswood
Journal:  Pediatr Nephrol       Date:  2017-10-09       Impact factor: 3.714

Review 9.  Renal Manifestations of Tuberous Sclerosis Complex.

Authors:  Nikhil Nair; Ronith Chakraborty; Zubin Mahajan; Aditya Sharma; Sidharth K Sethi; Rupesh Raina
Journal:  J Kidney Cancer VHL       Date:  2020-08-27

10.  Renal Angiomyolipoma: The Good, the Bad, and the Ugly.

Authors:  Nicolas Vos; Raymond Oyen
Journal:  J Belg Soc Radiol       Date:  2018-04-20       Impact factor: 1.894
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.